<?xml version="1.0" encoding="UTF-8"?>
<fig id="marinedrugs-18-00254-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>Effects of RS and oseltamivir on the production of neutralizing antibodies against IFV in serum samples of mice taken at 3, 7, or 14 days after IFV infection. IFV-infected mice were subcutaneously injected with or without 5-FU and were orally administered with water (control), 5 mg of RS, and 0.5 of mg oseltamivir. Titers of neutralizing antibody in the serum are shown. Each value represents the mean ± S.D (days 3 and 7, 
   <italic>n</italic> = 5; day 14, 
   <italic>n</italic> = 6–11). * 
   <italic>p</italic> &lt; 0.05, ** 
   <italic>p</italic> &lt; 0.01, *** 
   <italic>p</italic> &lt; 0.001 versus the control group. 
   <sup>+</sup>
   <italic>p</italic> &lt; 0.05, 
   <sup>+++</sup>
   <italic>p</italic> &lt; 0.001 versus the control or RS-administered group.
  </p>
 </caption>
 <graphic xlink:href="marinedrugs-18-00254-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
